Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-3181
Curr Opin Investig Drugs 2004 Jul 01;57:760-5.
Show Gene links Show Anatomy links

Z-338. Zeria/Yamanouchi.

Lehmann A .


???displayArticle.abstract???
Zeria and Yamanouchi are co-developing Z-338, a thiazole-4-carboxamide derivative with prokinetic activities, as a potential treatment for dyspepsia and gastric motility disorders. This compound is currently in phase II clinical trials.

???displayArticle.pubmedLink??? 15298074